Good morning guys..:-) Just a quick question regarding possible treatment of HCV/HIV (separate and co-infected) with our BIT225. So far our trials are based in combination with interferon and ribavirin (IFN/RBV). As there are other newer drugs on the market is it possible that after successful results in this combination BIT225 may be combined with them also? And will it be possible just to include BIT225 with other regime of treatments after only short small trials or do you think the whole new set of data will be required before those new combinations can happen? I believe we will be a sounding success if we are just added to IFN/RBV treatment improving it significantly but there may be a scope for us to be part of ALL or majority of other treatments available out there. Do you see it as a possibility? Thank you in advance for your comments on the issue..:-)
- Forums
- ASX - By Stock
- BIT
- question re treatments
question re treatments
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M |
Open | High | Low | Value | Volume |
3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 720804 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 687471 | 0.030 |
2 | 988888 | 0.029 |
5 | 618000 | 0.028 |
3 | 567000 | 0.027 |
4 | 3124559 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 30000 | 1 |
0.035 | 299839 | 3 |
0.036 | 47708 | 1 |
0.037 | 537816 | 2 |
0.038 | 162500 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |